Established in 2005 through a Bill & Melinda Gates Foundation grant, IVCC works with industry, funding partners and researchers to develop new public health insecticides for use in LLINs, indoor residual spraying (IRS), and other vector control tools.

Šis el. laiškas ir bet kokia prisegta byla ar bylos gali turėti konfidencialios informacijos. Jei šį laišką gavote per klaidą, prašome apie tai pranešti asmeniui iš „ColorMatrix“, atsiuntusį Jums šį laišką bei nedelsiant ištrinti žinutę ir visas bylas, nenukopijavus jų ir neatidarius.

Avient reflects 2022 estimated revenue of $5,100M and estimated CAPEX of $90M (excludes IT system upgrade of $25M and synergy capture CAPEX of $20M) Avient Specialty Other Free Cash Flow Conversion (1) 2022E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $635M and estimated CAPEX of $90M (excludes IT system upgrade of $25M and synergy capture CAPEX of $20M) Source: Peer data per Bloomberg market data as of February 15, 2022 86 89 85 80 76 76 89 85 79 78 76 76 76 70 69 63 8 LB Source: Peer data per Bloomberg market data as of February 15, 2022 Total Enterprise Value / 2022E EBITDAWith the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets. We expect this expansion to continue as we execute our strategy, increase margins and consistently grow earnings in excess of the market. 28 Avient reflects 2022 estimated EBITDA of $635M Past Avient valuations reflect forward 12 months EBITDA at December 31 of the respective years.

To provide comparable results, the company references “pro forma” financial metrics, which include the business results of Avient Protective Materials for periods prior to the Acquisition Date, as if the transaction occurred on January 1, 2021 and reflect Distribution as a discontinued operation. Avient reflects 2023 adjusted EBITDA guidance of $530M and estimated run-rate CAPEX of $110M. Avient Specialty Other Specialty / 2023E(%) 36 79 87 83 81 76 73 90 79 77 76 73 69 60 22 MULTIPLE EXPANSION Avient Specialty Other Specialty / Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.51.

Adjusted EPS 2006Y* 2007Y* 2008Y* 2009Y* 2010Y 2011Y 2012Y 2013Y 2014Y Net income attributable to PolyOne common shareholders $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 Joint venture equity earnings, after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) - - - Special items, after tax (21.2) 41.4 310.0 (31.0) 15.8 (30.5) 35.7 30.4 101.0 Tax adjustments (30.0) (30.7) 147.2 (44.9) (88.3) (42.3) 0.5 2.2 (10.5) Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 89.8 96.5 93.5 Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principal or discontinued operations. Gabelli Conf - POL IR Presentation ��PolyOne Investor Presentation�Gabelli Specialty Chemicals Conference�March 2015�� Forward-Looking Statements Use of Non-GAAP Measures PolyOne Commodity to Specialty Transformation PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Confirmation of Our Strategy Strategy and Execution Drive Results Proof of Performance & 2015 Goals Continuing Earnings Growth Innovation Drives Earnings Growth Megatrends Aligned with Key End Markets Debt Maturities & Pension Funding – 12/31/14 Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return PolyOne Core Values Why Invest In PolyOne?

Adjusted EPS attributable to PolyOne common shareholders is calculated as follows: 2009* 2010 2011 2012 2013 2014 2015 2016 Net income attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 165.2 Joint venture equity earnings, after tax (19.0) (14.7) (3.7) — — — — — Special items, before tax(1) (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 35.5 Special items, tax adjustments(1) (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (20.7) Adjusted net income attributable to PolyOne common shareholders $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 180.0 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.13 Adjusted operating income is calculated as follows: 2006* 2016 Operating income $ 233.6 $ 281.9 Special items (1) (39.1) 35.3 Joint venture equity earnings (107.0) 0.0 Adjusted operating income $ 87.5 $ 317.2 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation IR Presentation - Q4 2016v13 PolyOne Investor �Presentation�March 2017 Forward-Looking Statements Use of Non-GAAP Measures What We Do At a Glance Returning Cash to Shareholders Slide Number 7 Proof of Performance & 2020 Platinum Vision Ours is Not a Cost Cutting Story Innovation Drives Earnings Growth Primary Industries Served Slide Number 12 Slide Number 13 Slide Number 14 Slide Number 15 Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return Why Invest In PolyOne?

FX +4.6% FX -1.5% Total Avient +3.1% Note: Regional Sales Percentages exclude impact of foreign exchange Q2 2024 SEGMENT PERFORMANCE (COLOR, ADDITIVES & INKS) $525 $542 $94 $108 19.9% (in millions) (in millions) 10 17.9% +200 bps * Adjusted EBITDA Margin % • Organic sales growth in all regions led by Americas • Raw material deflation combined with cost reduction actions drove EBITDA margin expansion + 3% (+5% excluding FX) + 15% (+17% excluding FX) Q2 2024 SEGMENT PERFORMANCE (SPECIALTY ENGINEERED MATERIALS) $301 $308 $60 $64 20.6% (in millions) (in millions) 11 19.8% +80 bps * Adjusted EBITDA Margin % • Sales growth in consumer, healthcare and building & construction end markets offset by weaker demand in telecommunications • EBITDA margin expansion driven by positive end market mix as well as raw material deflation + 2% (+4% excluding FX) + 7% (+8% excluding FX) 2024 G U IDA N CE FY 2024 GUIDANCE Previous (May 7) Current Adjusted EBITDA $510 to $535 million $515 to $540 million Adjusted EPS $2.50 to $2.65 $2.55 to $2.70 Interest Expense $105 million $105 million Adjusted Effective Tax Rate 23% to 25% 23% to 25% Capital Expenditures ~$140 million ~$140 million 13 Q3 2024: Adjusted EPS of $0.62 14 Highlights • Provides performance updates on 2030 Sustainability Goals • Reduced company’s Scope 1 & 2 GHG emissions by 48% since 2019 • Highlights ESG performance ratings, certifications, and awards, including recent upgrades by Ecovadis to Gold and CDP to A- • Reflects Great Place to Work® culture focused on health, safety and employee engagement 2023 SUSTAINABILITY REPORT 14 Sustainability for a Better Tomorrow 2023 SUSTAINABILITY REPORT 15 • Investor Day to be held December 4, 2024 in New York, NY • The focus will be to do a deep dive on the Company’s strategy • Further details to be communicated 2024 AVIENT INVESTOR DAY AP P EN D IX 18 Performance Additives 15% Pigments TiO2 Dyestuffs Polyethylene 10%Nylon Polypropylene Styrenic Block Copolymer Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RAW MATERIAL BASKET SEGMENT DATA U.S. & Canada 41% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS 19% 23%Industrial Building and END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) 20 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2023 REVENUE | $2 .0 B ILL ION 34% 37% 21% END MARKET REGION 21 34% 21% 15% Building & 1% Energy COLOR, ADDITIVES & INKS 2023 REVENUE | $1 .1 B ILL ION 52% 35% 22 6%Industrial 12% 10% Defense Building & END MARKET REGION SPECIALTY ENGINEERED MATERIALS 32% 26% Building & 6% 2% Defense 1% (18% of sales) 2023 AVIENT REGIONAL SALES 25% Building & (36% of sales)Transportation 22% Building & 12% 6% US & Canada (41% of sales) 59% 22% Building & LATAM (5% of sales) 23 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results. A reconciliation of these measures to their most directly comparable GAAP measures is provided in the tables below. 2024 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income from continuing operations attributable to Avient shareholders $ 33.6 $ 0.36 $ 22.1 $ 0.24 Special items, after-tax 21.8 0.24 19.6 0.21 Amortization expense, after-tax 14.8 0.16 16.2 0.18 Adjusted net income / EPS $ 70.2 $ 0.76 $ 57.9 $ 0.63 Three Months Ended Reconciliation to EBITDA and Adjusted EBITDA: 2024 2023 Net income from continuing operations – GAAP $ 33.8 $ 22.3 Income tax expense 11.2 10.4 Interest expense, net 26.6 29.4 Depreciation & amortization 44.9 47.6 EBITDA from continuing operations $ 116.5 $ 109.7 Special items, before tax 28.1 21.7 Interest expense included in special items (1.0) — Depreciation & amortization included in special items (0.3) (0.1) Adjusted EBITDA $ 143.3 $ 131.3 Adjusted EBITDA as a percent of sales 16.9 % 15.9 % 1 2024 2023 Sales: Color, Additives and Inks $ 542.0 $ 524.5 Specialty Engineered Materials 308.1 300.8 Corporate (0.4) (0.9) Sales $ 849.7 $ 824.4 Operating income: Color, Additives and Inks $ 86.1 $ 68.0 Specialty Engineered Materials 42.8 39.7 Corporate (56.4) (45.4) Operating income $ 72.5 $ 62.3 Depreciation & amortization: Color, Additives and Inks $ 21.8 $ 25.7 Specialty Engineered Materials 20.8 19.9 Corporate 2.3 2.0 Depreciation & amortization $ 44.9 $ 47.6 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 107.9 $ 93.7 Specialty Engineered Materials 63.6 59.6 Corporate (54.1) (43.4) Other expense, net (0.9) (0.2) EBITDA from continuing operations 116.5 109.7 Special items, before tax 28.1 21.7 Interest expense included in special items (1.0) — Depreciation & amortization included in special items (0.3) (0.1) Adjusted EBITDA $ 143.3 $ 131.3 Adjusted EBITDA as a percent of sales: Color, Additives and Inks 19.9 % 17.9 % Specialty Engineered Materials 20.6 % 19.8 % Year Ended December 31, 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS Net income from continuing operations attributable to Avient shareholders $ 75.8 $ 0.83 Special items, after-tax 79.3 0.86 Amortization expense, after-tax 61.5 0.67 Adjusted net income / EPS $ 216.6 $ 2.36 Adjusted Free Cash Flow Calculation December 31, 2023 Cash provided by operating activities $ 201.6 Capital expenditures (119.4) Free cash flow 82.2 Taxes paid on gain on sale of business 104.1 Adjusted free cash flow $ 186.3 Year Ended December 31, 2023 Sales: Color, Additives and Inks $ 2,007.4 Specialty Engineered Materials 1,138.2 Corporate (2.8) Sales $ 3,142.8 Operating income: Color, Additives and Inks $ 259.9 Specialty Engineered Materials 142.5 Corporate (205.6) Operating income $ 196.8 Depreciation & amortization: Color, Additives and Inks $ 98.3 Specialty Engineered Materials 81.5 Corporate 9.0 Depreciation & amortization $ 188.8 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 358.2 Specialty Engineered Materials 224.0 Corporate (196.6) Other income, net 5.8 EBITDA from continuing operations 391.4 Special items, before tax 114.6 Interest expense included in special items (2.3) Depreciation & amortization included in special items (1.9) Adjusted EBITDA $ 501.8 Adjusted EBITDA as a percent of sales 16.0 % 3 AVNT M8 Investor Presentation.pdf Avient Disclaimer SLide.pdf AVNT M8 Investor Presentation IR Deck - AVNT-2024.06.30 (M8) (8.26.24 11AM Milestone August 26 1053 am).pdf Attachment

D is t. ) Avient reflects 2021 estimated revenue of $4,750M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Avient Specialty Other Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $580M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) 86 92 85 82 79 77 74 89 83 82 80 79 79 78 78 72 33 en t (12) Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the median of other selected chemical / specialty companies. With the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 24 Avient reflects 2021 estimated EBITDA of $580M OUR VALUATION VERSUS PEERS Avient Specialty Other 11.0 18.3 16.3 15.4 14.5 11.6 11.1 36.2 28.0 24.9 13.0 11.5 11.3 10.0 9.2 8.8 7.7 6.7 en t SUMMARY: WHY INVEST IN AVIENT?

We are pleased to announce this latest increase of 12%, which reflects the record adjusted EPS we project for 2021 and the confidence we have in our portfolio of sustainable solutions and future growth projections."

over the coming days, and the discussions will reflect